Literature DB >> 22017873

Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

Inna S Afonina1, Graham A Tynan, Susan E Logue, Sean P Cullen, Michael Bots, Alexander U Lüthi, Emer P Reeves, Noel G McElvaney, Jan P Medema, Ed C Lavelle, Seamus J Martin.   

Abstract

Granzyme B is a cytotoxic lymphocyte-derived protease that plays a central role in promoting apoptosis of virus-infected target cells, through direct proteolysis and activation of constituents of the cell death machinery. However, previous studies have also implicated granzymes A and B in the production of proinflammatory cytokines, via a mechanism that remains undefined. Here we show that IL-1α is a substrate for granzyme B and that proteolysis potently enhanced the biological activity of this cytokine in vitro as well as in vivo. Consistent with this, compared with full-length IL-1α, granzyme B-processed IL-1α exhibited more potent activity as an immunoadjuvant in vivo. Furthermore, proteolysis of IL-1α within the same region, by proteases such as calpain and elastase, was also found to enhance its biological potency. Thus, IL-1α processing by multiple immune-related proteases, including granzyme B, acts as a switch to enhance the proinflammatory properties of this cytokine.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017873      PMCID: PMC3319689          DOI: 10.1016/j.molcel.2011.07.037

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

Authors:  N G McElvaney; R C Hubbard; P Birrer; M S Chernick; D B Caplan; M M Frank; R G Crystal
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

3.  Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor.

Authors:  L M Carruth; S Demczuk; S B Mizel
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

4.  Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein.

Authors:  D J Hazuda; J Strickler; P Simon; P R Young
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

5.  Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

Authors:  R A Black; S R Kronheim; M Cantrell; M C Deeley; C J March; K S Prickett; J Wignall; P J Conlon; D Cosman; T P Hopp
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

6.  Localization of human mononuclear cell interleukin 1.

Authors:  P J Conlon; K H Grabstein; A Alpert; K S Prickett; T P Hopp; S Gillis
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

7.  Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

Authors:  B Mosley; S K Dower; S Gillis; D Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.

Authors:  B Mosley; D L Urdal; K S Prickett; A Larsen; D Cosman; P J Conlon; S Gillis; S K Dower
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  Discordant regulation of granzyme H and granzyme B expression in human lymphocytes.

Authors:  Karin A Sedelies; Thomas J Sayers; Kirsten M Edwards; Weisan Chen; Daniel G Pellicci; Dale I Godfrey; Joseph A Trapani
Journal:  J Biol Chem       Date:  2004-04-06       Impact factor: 5.157

10.  Identification of a membrane-associated interleukin 1 in macrophages.

Authors:  E A Kurt-Jones; D I Beller; S B Mizel; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  114 in total

1.  Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice.

Authors:  Lars T Joeckel; Reinhard Wallich; Sunil S Metkar; Christopher J Froelich; Markus M Simon; Christoph Borner
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G.

Authors:  Emma Lefrançais; Stephane Roga; Violette Gautier; Anne Gonzalez-de-Peredo; Bernard Monsarrat; Jean-Philippe Girard; Corinne Cayrol
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 3.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

4.  Pneumolysin-Dependent Calpain Activation and Interleukin-1α Secretion in Macrophages Infected with Streptococcus pneumoniae.

Authors:  Rendong Fang; Rui Wu; Huihui Du; Meilan Jin; Yajing Liu; Guihua Lei; Bing Jiang; Zehui Lei; Yuanyi Peng; Kui Nie; Kohsuke Tsuchiya
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 5.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

6.  The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis.

Authors:  Maryse Dagenais; Jeremy Dupaul-Chicoine; Todd Douglas; Claudia Champagne; Alexandre Morizot; Maya Saleh
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

7.  Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity.

Authors:  Saranya Elavazhagan; Kavin Fatehchand; Vikram Santhanam; Huiqing Fang; Li Ren; Shalini Gautam; Brenda Reader; Xiaokui Mo; Carolyn Cheney; Edward Briercheck; John P Vasilakos; Gregory N Dietsch; Robert M Hershberg; Michael Caligiuri; John C Byrd; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

Review 8.  Inflammasomes in the CNS.

Authors:  John G Walsh; Daniel A Muruve; Christopher Power
Journal:  Nat Rev Neurosci       Date:  2014-01-08       Impact factor: 34.870

9.  Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.

Authors:  Shahzma Merani; George A Kuchel; Alison Kleppinger; Janet E McElhaney
Journal:  Exp Gerontol       Date:  2017-09-27       Impact factor: 4.032

Review 10.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.